Educational resources

This section includes resources developed by Guidelines, including algorithms, eLearning modules, medicines appraisal cards, supplements, and videos.

Latest videos

Sign 154 video

Video: SIGN 154: Pharmacological management of glycaemic control in people with type 2 diabetes

2018-04-16T13:27:00+01:00Funded by Napp Pharmaceuticals Limited

Rifaximin for hepatic encephalopathy

Video: Rifaximin-α for hepatic encephalopathy1—Impact on NHS resources and the IMPRESS study

2018-04-08T03:37:00+01:00Commissioned by Norgine Pharmaceuticals Limited

Dry skin and eczema—a cost effectiveness analysis of patient emollient therapy and prescriptions in uk primary care

Health Plus Care symposium presentation on the cost effectiveness of prescribing emollient therapy in dry skin and eczema

2017-12-19T15:26:00+00:00Commissioned by Johnson & Johnson Ltd

Bts sign video hilary pinnock thumbnail

Video: BTS/SIGN 2016 update to British guideline on the management of asthma

2016-11-28T15:47:00+00:00Funded by Chiesi Ltd

Teva Spotlight resource hub

Spotlight ad

Spotlight portfolio of medicines

Spotlight price list

Information from Teva UK Limited

Spotlight carousel image

Teva Spotlight resource hub

  • Spotlight portfolio of medicines

  • Information from Teva UK Limited

  • Teva Spotlight resource hub

Latest supplements

Guidelines supplements are written by experts and typically discuss a piece of national guidance, pulling out key learning points for GPs.

20180904 Flynn ADHD supplement v4

Recognising and managing adult ADHD in primary care

2018-11-22T09:48:15.67+00:00By Commissioned by Flynn Pharma Ltd.

Latest medicines appraisal cards

Medicines appraisal cards have been developed for the Guidelines audience to announce new recommendations from the National Institute for Health and Care Excellence (NICE), the Scottish Medicines Consortium (SMC), and the All Wales Medicines Strategy Group (AWMSG).

spiriva smc card

Tiotropium 2.5 microgram inhalation solution (Spiriva® Respimat®)
SMC No. (411/07)

2017-12-15T09:24:00+00:00Commissioned by Boehringer Ingelheim Limited

Commissioned by Boehringer Ingelheim Limited

Validate Accessibility